New Key Statistics Module, Z-Score and F-Score
SZSE:000590 Key Ratios
| Market Cap ¥ M | 1,688.48 |
| Enterprise Value ¥ M | 1,575.08 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.42 |
| Price/Sales | 4.82 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) ¥ M | 346.00 |
| EPS (TTM) ¥ | -0.04 |
| Beneish M-Score | -2.53 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -112.30 |
| EV-to-EBIT | -902.62 |
| EV-to-EBITDA | -902.62 |
| PEG | -- |
| Shares Outstanding M | 239.47 |
| Net Margin (%) | -2.78 |
| Operating Margin % | -3.62 |
| Pre-tax Margin (%) | -1.60 |
| Quick Ratio | 1.55 |
| Current Ratio | 2.22 |
| ROA % (ttm) | -0.85 |
| ROE % (ttm) | -1.36 |
| ROIC % (ttm) | -2.85 |
| Dividend Yield % | -- |
| Altman Z-Score | 2.81 |
SZSE:000590 Number of Guru Trades
SZSE:000590 Volume of Guru Trades
Gurus Latest Trades with SZSE:000590
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:000590 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Tus-Pharmaceutical Group Co Ltd Insider Transactions
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers